Shanghai Green Valley Pharmaceutical Co
Shanghai Green Valley Pharmaceutical Co, located in the biomedical valley of Zhangjiang National Innvoation Demonstration Zone in Shanghai, was co-founded together with the Shanghai Institute of Materia Medica, Chinese Academy of Sciences (CAS) in 2000.
After ten years' development, it has become an integrated pharmaceutical enterprise combining research and sales.
The company insists on originality, and devotes itself to the modernization of traditional Chinese medicine. Its products are at international standards, and it has become one of the 20 most innovative Chinese pharmaceutical companies.
Cardiovascular and cerebrovascular diseases, senile dementia, tumor, diabetes and other chronic diseases have become the No 1 killers. The company keeps exploring new ways of drug therapy and new pharmaceuticals, improving its research and technology to the first-class level.
The company has set up a research institute, calling together CAS academicians, scientists with overseas background, and personnel from national human resource programs. The company spends 25 percent of its revenues each year on research investments. It has developed a research network with several branches.
In 2010,China became the second largest economy in the world, and in 2013,China became the second largest pharmaceutical market in the world. The 21st century is meant to be a golden age for Chinese pharmaceuticals. The company believes in China’s capacity, and is well prepared to become an international leader.